| PUBLICATIONS (Ranked by Impact Factor of the Journal) | DIABETES Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9 The aim of the study was to determine the role of class IIa histone deacetylases in pancreas development. [Diabetes] Abstract Survival of Pancreatic Beta-Cells Is Partly Controlled by a TCF7L2 – p53 – p53INP1 Dependent Pathway The aim of the study was to identify the molecular mechanism through which T-cell factor 7-like 2 (TCF7L2) influences beta-cell survival. [Hum Mol Genet] Abstract Pancreatic Islet and Progenitor Cell Surface Markers with Cell Sorting Potential The aim of the study was to identify surface bio-markers and corresponding antibody tools that can be used for the imaging and immunoisolation of the pancreatic beta cell and its progenitors. [Diabetologia] Abstract TNF-Related Apoptosis-Inducing Ligand (TRAIL) Protects Against Diabetes and Atherosclerosis in Apoe−/− Mice Investigators show for the first time that TRAIL deficiency promotes numerous features of diabetes that are typical of human disease, and are associated with reduced insulin and pancreatic inflammation/apoptosis. [Diabetologia] Abstract Loss of Foxd3 Results in Decreased β-Cell Proliferation and Glucose Intolerance During Pregnancy Here, investigators show that mice carrying a pancreas-specific deletion of Foxd3 have impaired glucose tolerance, decreased β-cell mass, decreased β-cell proliferation, and decreased β-cell size during pregnancy. [Endocrinology] Abstract PANCREATIC CANCER EGFR-Dependent Pancreatic Carcinoma Cell Metastasis Through Rap1 Activation Here, researchers describe an epidermal growth factor receptor (EGFR)-mediated signaling pathway that regulates human pancreatic carcinoma cell invasion and metastasis, yet does not influence the growth of primary tumors. [Oncogene] Abstract Growth of the Pancreatic Cancer Cell Line PANC-1 Is Inhibited by Protein Phosphatase 2A Inhibitors Through Overactivation of the c-Jun N-terminal Kinase Pathway In this study, researchers have confirmed that the basal activity of the phospatidylinositol 3-kinase/JNK/activator protein 1 pathway promoted pancreatic cancer cell growth when stimulated by growth factors. [Eur J Cancer] Abstract Significance of Combination Therapy of Zoledronic Acid and Gemcitabine on Pancreatic Cancer In this study, researchers examined the cytotoxic effects of combination therapy with zoledronic acid and gemcitabine on pancreatic cancer cells in vitro and in vivo. [Cancer Sci] Abstract Role of Alpha5 Beta1 Integrin Upregulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells Scientists utilized naturally serum-free, selectively permeable basement membranes, and confocal microscopy of fluorescent antibody-stained, cultured human Panc-1, MiaPaCa-2 and BxPC-3 pancreatic cancer cell lines to investigate the effects of ionizing radiation on α5β1 integrin fibronectin receptor expression and invasion. [Transl Oncol] Abstract Use of a Mouse Model of Pancreatic Neuroendocrine Tumors to Find Pericyte Biomarkers of Resistance to Anti-Angiogenic Therapy Herein, by the use of a genetically engineered mouse model of pancreatic neuroendocrine tumors, researchers have assessed the utility of pericyte characteristics in terms of differential marker expression to serve as surrogate markers for response or evasive resistance to anti-angiogenic therapy. [Horm Metab Res] Abstract |
|
|
|